BENYLIN

This brand name is authorized in Cyprus, Ireland, Malta, United Kingdom

Active ingredients

The drug BENYLIN contains a combination of these active pharmaceutical ingredients (APIs):

1 Diphenhydramine UNII TC2D6JAD40 - DIPHENHYDRAMINE HYDROCHLORIDE

Diphenhydramine is an ethanolamine-derivative antihistamine. It is an antihistamine with anticholinergic and marked sedative effects. It acts by inhibiting the effects on H1-receptors. Diphenhydramine is effective in reducing sleep onset (i.e., time to fall asleep) and increasing the depth and quality of sleep. Read about Diphenhydramine

2 Menthol UNII BZ1R15MTK7 - LEVOMENTHOL

Read about Menthol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BENYLIN MUCUS COUGH MAX Oral solution	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
BENYLIN DRY COUGHS Syrup	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R06AA02	Diphenhydramine	R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AA Aminoalkyl ethers
Discover more medicines within R06AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 129538, 49465
Country: MT	Medicines Authority	Identifier(s): MA1315/00202